Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 158

1.

Diabetes-mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction.

Del Puerto-Nevado L, Santiago-Hernandez A, Solanes-Casado S, Gonzalez N, Ricote M, Corton M, Prieto I, Mas S, Sanz AB, Aguilera O, Gomez-Guerrero C, Ayuso C, Ortiz A, Rojo F, Egido J, Garcia-Foncillas J, Minguez P, Alvarez-Llamas G; DiabetesCancerConnect Consortium.

Mol Oncol. 2019 Jun 14. doi: 10.1002/1878-0261.12531. [Epub ahead of print]

2.

Strong antitumor activity of bevacizumab and aflibercept in Neuroendocrine Carcinomas: In-depth preclinical study.

Rodriguez-Remirez M, Del Puerto-Nevado L, Fernández Aceñero MJ, Ebrahimi-Nik H, Cruz-Ramos M, Garcia-Garcia L, Solanes S, Baños N, Molina-Roldan E, Garcia-Foncillas J, Cebrián A.

Neuroendocrinology. 2019 Apr 29. doi: 10.1159/000500591. [Epub ahead of print]

PMID:
31030198
3.

UNR/CSDE1 Expression Is Critical to Maintain Invasive Phenotype of Colorectal Cancer through Regulation of c-MYC and Epithelial-to-Mesenchymal Transition.

Martinez-Useros J, Garcia-Carbonero N, Li W, Fernandez-Aceñero MJ, Cristobal I, Rincon R, Rodriguez-Remirez M, Borrero-Palacios A, Garcia-Foncillas J.

J Clin Med. 2019 Apr 25;8(4). pii: E560. doi: 10.3390/jcm8040560.

4.

Post-translational regulation could determine functional differences between SET alpha and beta isoforms in chronic lymphocytic leukaemia.

Cristóbal I, Sanz-Alvarez M, Luque M, Rojo F, García-Foncillas J.

Br J Haematol. 2019 Apr 24. doi: 10.1111/bjh.15935. [Epub ahead of print] No abstract available.

PMID:
31020656
5.

Letter by Cristóbal et al Regarding Article, "Protein Phosphatase 2A Regulates Cardiac Na+ Channels".

Cristóbal I, Sanz-Alvarez M, Luque M, Rojo F, García-Foncillas J.

Circ Res. 2019 Apr 12;124(8):e59. doi: 10.1161/CIRCRESAHA.119.314905. No abstract available.

PMID:
30973817
6.

The Role of MicroRNAs in Hepatoblastoma Tumors.

Cristóbal I, Sanz-Álvarez M, Luque M, Caramés C, Rojo F, García-Foncillas J.

Cancers (Basel). 2019 Mar 22;11(3). pii: E409. doi: 10.3390/cancers11030409. Review.

7.

Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer.

Cristóbal I, Torrejón B, Rubio J, Santos A, Pedregal M, Caramés C, Zazo S, Luque M, Sanz-Alvarez M, Madoz-Gúrpide J, Rojo F, García-Foncillas J.

J Clin Med. 2019 Mar 12;8(3). pii: E346. doi: 10.3390/jcm8030346.

8.

Molecular evidence of field cancerization initiated by diabetes in colon cancer patients.

Del Puerto-Nevado L, Minguez P, Corton M, Solanes-Casado S, Prieto I, Mas S, Sanz AB, Gonzalez-Alonso P, Villaverde C, Portal-Nuñez S, Aguilera O, Gomez-Guerrero C, Esbrit P, Vivanco F, Gonzalez N, Ayuso C, Ortiz A, Rojo F, Egido J, Alvarez-Llamas G, Garcia-Foncillas J; DiabetesCancerConnect Consortium.

Mol Oncol. 2019 Apr;13(4):857-872. doi: 10.1002/1878-0261.12438. Epub 2019 Feb 16.

9.

EphB2 stem-related and EphA2 progression-related miRNA-based networks in progressive stages of CRC evolution: clinical significance and potential miRNA drivers.

De Robertis M, Mazza T, Fusilli C, Loiacono L, Poeta ML, Sanchez M, Massi E, Lamorte G, Diodoro MG, Pescarmona E, Signori E, Pesole G, Vescovi AL, Garcia-Foncillas J, Fazio VM.

Mol Cancer. 2018 Nov 30;17(1):169. doi: 10.1186/s12943-018-0912-z.

10.

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer.

García-Foncillas J, Tabernero J, Élez E, Aranda E, Benavides M, Camps C, Jantus-Lewintre E, López R, Muinelo-Romay L, Montagut C, Antón A, López G, Díaz-Rubio E, Rojo F, Vivancos A.

Br J Cancer. 2018 Dec;119(12):1464-1470. doi: 10.1038/s41416-018-0293-5. Epub 2018 Nov 23.

11.

Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer.

Cruz-Ramos M, Del Puerto-Nevado L, Zheng B, López-Bajo R, Cebrian A, Rodríguez-Remirez M, García-García L, Solanes-Casado S, García-Foncillas J.

J Geriatr Oncol. 2018 Oct 13. pii: S1879-4068(18)30256-X. doi: 10.1016/j.jgo.2018.10.002. [Epub ahead of print]

PMID:
30327283
12.

New Hope for Pancreatic Ductal Adenocarcinoma Treatment Targeting Endoplasmic Reticulum Stress Response: A Systematic Review.

Garcia-Carbonero N, Li W, Cabeza-Morales M, Martinez-Useros J, Garcia-Foncillas J.

Int J Mol Sci. 2018 Aug 21;19(9). pii: E2468. doi: 10.3390/ijms19092468. Review.

13.

Cancer and suicidal ideation and behaviours: protocol for a systematic review and meta-analysis.

Calati R, Fang F, Mostofsky E, Shen Q, Di Mattei VE, Garcia-Foncillas J, Baca-Garcia E, Cipriani A, Courtet P.

BMJ Open. 2018 Aug 10;8(8):e020463. doi: 10.1136/bmjopen-2017-020463.

14.

Analysis of Potential Alterations Affecting SETBP1 as a Novel Contributing Mechanism to Inhibit PP2A in Colorectal Cancer Patients.

Torrejón B, Cristóbal I, Caramés C, Prieto-Potín I, Chamizo C, Santos A, Sanz-Alvarez M, Serna-Blasco R, Luque M, Madoz-Gúrpide J, Rojo F, García-Foncillas J.

World J Surg. 2018 Nov;42(11):3771-3778. doi: 10.1007/s00268-018-4684-9.

PMID:
29796729
15.

Dissecting the therapeutic implications of the complex SMAD4 regulatory network in metastatic colorectal cancer.

Cristóbal I, Torrejón B, Santos A, Luque M, Sanz-Alvarez M, Rojo F, García-Foncillas J.

Eur J Surg Oncol. 2018 Aug;44(8):1283-1284. doi: 10.1016/j.ejso.2018.04.021. Epub 2018 May 9. No abstract available.

PMID:
29778618
16.

Potential Therapeutic Impact of miR-145 Deregulation in Colorectal Cancer.

Cristóbal I, Sanz-Alvarez M, Torrejón B, Santos A, Luque M, Rojo F, García-Foncillas J.

Mol Ther. 2018 Jun 6;26(6):1399-1400. doi: 10.1016/j.ymthe.2018.05.008. Epub 2018 May 18. No abstract available.

17.

The clinical impact of using complex molecular profiling strategies in routine oncology practice.

Laes JF, Aftimos P, Barthelemy P, Bellmunt J, Berchem G, Camps C, Peñas RL, Finzel A, García-Foncillas J, Hervonen P, Wahid I, Joensuu T, Kathan L, Kong A, Mackay J, Mikropoulos C, Mokbel K, Mouysset JL, Odarchenko S, Perren TJ, Pienaar R, Regonesi C, Alkhayyat SS, El Kinge AR, Abulkhair O, Galal KM, Ghanem H, El Karak F, Garcia A, Ghitti G, Sadik H.

Oncotarget. 2018 Apr 17;9(29):20282-20293. doi: 10.18632/oncotarget.24757. eCollection 2018 Apr 17.

18.

Comment on 'MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma'.

Cristóbal I, Santos A, González S, Luque M, Torrejón B, Rojo F, García-Foncillas J.

Br J Cancer. 2018 Apr;118(7):1028-1029. doi: 10.1038/s41416-018-0013-1. Epub 2018 Mar 19. No abstract available.

19.

Targeting the RAS-dependent chemoresistance: The Warburg connection.

Serna-Blasco R, Sanz-Álvarez M, Aguilera Ó, García-Foncillas J.

Semin Cancer Biol. 2019 Feb;54:80-90. doi: 10.1016/j.semcancer.2018.01.016. Epub 2018 Feb 9. Review.

PMID:
29432815
20.

Potential contribution of SET and c-MYC deregulation to promote extracellular matrix remodelling in hepatocellular carcinoma.

Cristóbal I, Torrejón B, Rojo F, García-Foncillas J.

Br J Pharmacol. 2018 Feb;175(3):573-574. doi: 10.1111/bph.14108. Epub 2018 Jan 5. No abstract available.

Supplemental Content

Loading ...
Support Center